...
Conditions
Interventions
Intervention 1: Patients are treated with EMLA cream. A 5%EMLA cream is a combination of 2.5% lidocaine and 2.5% perlocaine produced by Iranian chemistry company Iran. For each patient, 2 grams of 4 ×
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All adult patients referred to the emergency department of al-Zahra and Kashani hospitals Need for Peripheral Intravenous Cannulation Alert
Exclusion criteria
Exclusion criteria: The presence of visual, mental and verbal disorders Opioids addiction Sensitivity to anesthetic drugs Patients in a life-threatening condition Analgesic drug addict(More than 4 times a week)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of pain. Timepoint: After intravenous cannulation. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to start anesthetic effect. Timepoint: To an hour of exposure. Method of measurement: Time (minute).;Drug side effects such as redness, whitening and skin blemishes. Timepoint: Until the time of discharge. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Heydari
Esfahan University of Medical Sciences
Outcome results
None listed